Ultravist-240

Roman name

Ultravist # 8238

The composition and the form of

1 ml solution for injection (Ultravist-240) contains iopromida 499 mg (corresponding to 240 mg iodine); Patients in the 10 and 50 ml, in a carton st.1 10 ml solution for injection (Ultravist 300), 623 mg (corresponding to 300 mg iodine); Patients in the 10, 20, 50 and 100 ml, in a carton st.1 10 ml solution for injection (Ultravist - 370), 769 mg (corresponding to 370 mg iodine); Patients in the 30, 50 and 100 ml, in a cardboard box 10 pcs.

Characteristics

Neine rentgencontrastnoe vehicle launched kidneys low osmoticski pressure.

Of drugs

Rentgencontrastnoe. The availability of stable iodine absorbed X-ray beams, and ensures a high degree of opacity of the study.

Pharmacokinetics

After the on / in a distributed mainly in vnecleternm space; Displayed mainly kidneys. After 24 hours more than 92% of drugs are removed from the organism.

Clinical pharmacology

Following the introduction of Ultravist patients or healthy volunteers clinically significant changes in laboratory values or vital functions were observed. The doses used little influence on the permeability of GEB, the nervous, cardiovascular and urinary systems of the body.

Indications

Computed tomography (CT), angiography (including digital angiography substraktinaya) urografia, flebografia study cavities of the body (artrografia, endoscopic retrogradnaya holangiopankreatografia, Hysterosalpingography, galactografia); With a subarahnoidalnom - mielografia, Kt-mielografia (for Ultravist-240).

Pregnancy and lactation

If pregnancy should carefully assess the potential risks associated with rentgencontrastnam study.

Contraindications

Expressed Ray; Can be гистеросальпингограф ию in pregnancy and acute inflammatory processes in the area of the pelvis.

Side-Effects

There may be nausea, vomiting, hyperemia, fever and pain (during vnutrisosudistogo introduction); Rarely shock response (similar to vascular collapse).

Precautions

The caution should be applied in гиперчувствительност и to yodsoderjasim means circulatory failure events decompensation, severe violations of the liver and kidney, lung emphysema expressed farm cerebrovascular, decompencirovannom diabetes, high blood coagulability uzlovatom zobe, plazmotsytome, generally serious condition.

Dosing and Administration

Dose depends on the age and body mass index patient minutes of the heart, diagnostic tasks, the type of technical equipment, as well as the type and amount of blood vessels inside Oblasti.rastvor is only designed for one-time use, and should be typed in a syringe or a bottle of the drip only at the start of the study. The study should be carried out erh, but necessarily in the normal vodno-elektrolitnogo balance. Any violations should be корригировать.Нормал��ная Diet can be maintained until two hours before the study. During the past two hours she must abstain from food. Prolonged abstinence from food and reception slabitelnogo the study protivopokazana if the study infants and preschool children возраста.Внутрисосуд��стое introduction should be done when the patient is in the trunk; after, the patient should see at least 30 minutes. There is a need to minimize the contact between blood and contrasting substance in the syringes and kateterh, as well as to monitor carefully the technology angiography and often washed catheter saline solution (if necessary with the addition of heparin), in order to avoid the risk of thromboembolitic complications.

Storage conditions

r-r d / in. : List B. In the dark place at a temperature of no higher than 30 ° C

Shelf life

r-r d / in. : 3 and

Directory → Diagnostic tools → Edgy funds → Ultravist-240